Alfasigma: INTERCEPT PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intercept Pharmaceuticals, Inc. - ICPT

(marketscreener.com) Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC are investigating the proposed sale of Intercept Pharmaceuticals, Inc. to Alfasigma S.p.A. Under the terms of the proposed transaction, shareholders of Intercept will receive $19.00 in cash for each share of Intercept that they own....https://www.marketscreener.com/quote/stock/INTERCEPT-PHARMACEUTICALS-11718561/news/INTERCEPT-PHARMACEUTICALS-INVESTOR-ALERT-by-the-Former-Attorney-General-of-Louisiana-Kahn-Swick-F-44935063/?utm_medium=RSS&utm_content=20230927